Model for end-stage liver disease and model for end-stage liver disease-na scores predict both before-listing and wait-list mortality

Transplantation Proceedings

Volumn 44, Issue 2, 2012, Pages 389-392

  Yamashiki, N ^a   Sugawara, Y ^b   Tamura, S ^b   Kaneko, J ^b   Nojiri, K ^c   Aoki, T ^b   Sakamoto, Y ^b   Hasegawa, K ^b   Koike, K ^a   Kokudo, N ^b  

^a Artificial Organ and Transplantation Division   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; SODIUM;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CADAVER DONOR; CHILD; CHILD PUGH TURCOTTE SCORE; END STAGE LIVER DISEASE; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRESCHOOL CHILD; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; JAPAN; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SODIUM; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS; YOUNG ADULT;

EID: 84858198829     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.01.037     Document Type: Article

References (10)

1. R.L. Carithers Jr Liver transplantation American Association for the Study of Liver Diseases Liver Transpl 6 2000 122
2. R.H. Wiesner, S.V. McDiarmid, P.S. Kamath MELD and PELD: application of survival models to liver allocation Liver Transpl 7 2001 567
3. P.S. Kamath, W.R. Kim The model for end-stage liver disease (MELD) Hepatology 45 2007 797
4. W.R. Kim, S.W. Biggins, W.K. Kremers Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018
5. The Japanese Liver Transplantation Society Liver Transplantation in JapanRegistry by the Japanese Liver Transplantation Society Japanese Journal of Transplantation 45 2010 621
6. R.M. Merion, D.E. Schaubel, D.M. Dykstra The survival benefit of liver transplantation Am J Transplant 5 2005 307
7. V.R. Julapalli, J.R. Kramer, H.B. El-Serag Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center Liver Transpl 11 2005 1370
8. J. Alali, A. Ramji, J.K. Ho Liver transplant candidacy unsuitability: a review of the British Columbia experience Can J Gastroenterol 20 2006 95
9. V. Medici, L. Rossaro, J.A. Wegelin The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral Liver Transpl 14 2008 1100
10. N. Yamashiki, Y. Sugawara, S. Tamura Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease Liver Transpl 12 2006 1077